Neurodegenerative Disorders: A Wealth Of Opportunities For Digital Technologies

Access the Research Report: Neurodegenerative Disorders: A Wealth Of Opportunities For Digital Technologies

Trials in neurodegenerative diseases are highly complex, with the biggest issues cited as trial recruitment and drug delivery across the blood-brain barrier. Pharma and biotech have huge opportunities, but only with the right technology, partnerships and tools.

Hear from industry leaders on how digital tools, AI/ML and CROs are helping navigate complexities and drive innovation, including insights on:

Key barriers to success from trial recruitment to blood-brain barrier drug delivery
How digital health tools such as eCOA, and regulatory guidelines ICH E6(R3) are impacting trials
AI/ML in trial design, optimization and future potential
Where CROs remain most useful and where challenges remain
Game-changing breakthroughs set to reshape the research landscape in the next 5-10 years

Simply complete the form to download your free Research Report.

Work Email Address*

Role

Country*

I have read and agree to the below privacy policies

By ticking this box, you agree to receive emails from Citeline, and carefully selected partners

Lead Source - PI Partner

Primary Product Interest*

You agree Citeline and Allucent may contact you directly about industry news, products, services and events that may be of interest to you subject to the privacy policies of Citeline and Allucent

Overcoming barriers in neurodegenerative R&D

Access the Research Report: Neurodegenerative Disorders: A Wealth Of Opportunities For Digital Technologies

Simply complete the form to download your free Research Report.